137 related articles for article (PubMed ID: 36073223)
1. [Survival rate and quality of life of human papillomaviruse-negative patients with advanced oropharyngeal cancer receiving different treatments].
Li J; Guo Y; Cui W; Sun Y; Yang D; Liu L; Wu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1230-1236. PubMed ID: 36073223
[TBL] [Abstract][Full Text] [Related]
2. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
Inhestern J; Schmalenberg H; Dietz A; Rotter N; Maschmeyer G; Jungehülsing M; Grosse-Thie C; Kuhnt T; Görner M; Sudhoff H; Wittekindt C; Guntinas-Lichius O
Ann Oncol; 2017 Aug; 28(8):1917-1922. PubMed ID: 28498880
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and survival of patients with oropharyngeal cancer.
Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
[TBL] [Abstract][Full Text] [Related]
4. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
Yver CM; Shimunov D; Weinstein GS; Rajasekaran K; Cannady SB; Lukens JN; Lin A; Swisher-McClure S; Cohen RB; Aggarwal C; Bauml JM; Loevner LA; Newman JG; Chalian AA; Rassekh CH; Basu D; O'Malley BW; Brody RM
Oral Oncol; 2021 Jul; 118():105307. PubMed ID: 33932874
[TBL] [Abstract][Full Text] [Related]
5. Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis.
DE Felice F; Abate G; Galdieri A; Bulzonetti N; Musio D; Tombolini V
Anticancer Res; 2016 Dec; 36(12):6667-6672. PubMed ID: 27920000
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
[TBL] [Abstract][Full Text] [Related]
7. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
8. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
Staar S; Rudat V; Stuetzer H; Dietz A; Volling P; Schroeder M; Flentje M; Eckel HE; Mueller RP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1161-71. PubMed ID: 11483325
[TBL] [Abstract][Full Text] [Related]
9. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
Garden AS; Gunn GB; Hessel A; Beadle BM; Ahmed S; El-Naggar AK; Fuller CD; Byers LA; Phan J; Frank SJ; Morrison WH; Kies MS; Rosenthal DI; Sturgis EM
Cancer; 2014 Oct; 120(19):3082-8. PubMed ID: 24898672
[TBL] [Abstract][Full Text] [Related]
10. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR
Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470
[TBL] [Abstract][Full Text] [Related]
11. Impact of Different Treatment Concepts on Regional Failure in Advanced Oropharyngeal Cancer.
Hoch S; Thelen K; Vorwerk H; Netzer C; Wilhelm T; Günzel T; Teymoortash A
Anticancer Res; 2017 Feb; 37(2):727-734. PubMed ID: 28179323
[TBL] [Abstract][Full Text] [Related]
12. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
14. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer.
Chen AM; Daly ME; Luu Q; Donald PJ; Farwell DG
Head Neck; 2015 Mar; 37(3):381-5. PubMed ID: 24431059
[TBL] [Abstract][Full Text] [Related]
15. Comparison of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced oropharyngeal cancers: a phase III randomised trial.
Rishi A; Ghoshal S; Verma R; Oinam AS; Patil VM; Mohinder R; Sharma SC
Radiother Oncol; 2013 Jun; 107(3):317-24. PubMed ID: 23746674
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia during radiotherapy in patients with oropharyngeal cancer.
Ng SP; Bahig H; Jethanandani A; Pollard C; Berends J; Sturgis EM; Johnson FM; Elgohari B; Elhalawani H; Rosenthal DI; Skinner HD; Gunn GB; Phan J; Frank SJ; Mohamed ASR; Fuller CD; Garden AS
Radiother Oncol; 2020 Apr; 145():95-100. PubMed ID: 31931292
[TBL] [Abstract][Full Text] [Related]
17. The role of concomitant chemoradiotherapy in AJCC 7
Lu DJ; Luu M; Nguyen AT; Shiao SL; Scher K; Mita A; Anderson E; Clair JM; Ho AS; Zumsteg ZS
Oral Oncol; 2020 Nov; 110():104882. PubMed ID: 32650257
[TBL] [Abstract][Full Text] [Related]
18. Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer
Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Kempel MM; Meidahl Petersen P; Borre M
Scand J Urol; 2017 Dec; 51(6):457-463. PubMed ID: 28748716
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients.
Høxbroe Michaelsen S; Grønhøj C; Høxbroe Michaelsen J; Friborg J; von Buchwald C
Eur J Cancer; 2017 Jun; 78():91-102. PubMed ID: 28431302
[TBL] [Abstract][Full Text] [Related]
20. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
